6 results
management diagnosis hematology activation algorithm antinxp2 antinxp2dm blood brain cardiomyopathy crypto cryptococcal dermatology dermatomyositis guidelines macrophage mas meningitis mri nodosa
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Severe Disease → Remission
• Non-Severe Disease ... immunosuppressive agent (e.g ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Blood Product Transfusions One Pager Summary Type and screen - determines blood type and detects in recipient
in recipient (e.g ... Graft Versus Host Disease ... RBCs (stored at 4C ... Borrellia (Lyme disease ... diagnosis #management #hematology
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
fever syndromes Clinical ... Fever is the main clinical ... Fibrin degradation products ... Treatment: • Corticosteroids ... #Rheumatology
Peripartum Cardiomyopathy - Summary 1. Definition • Towards the end of pregnancy to 5 months postpartum
exertion, orthopnea, PND ... Avoid estrogen products ... support for patients clinically ... diagnosis #management #cardiology ... #treatment
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
chest (in a V-sign ... auricular papules Clinical ... more severe disease ... positive patients Treatment ... diagnosis #management #rheumatology
Cryptococcal meningitis on T2 MRI 30 M from sub-Saharan Africa presents w/ progressive Headache x1 mo, +neck
gelatinous cyst produced ... organism (soap bubble sign ... Standard treatment ... University Infectious Diseases ... T2 #MRI #Brain #clinical
No results found for "PAD cardiology sign injection ekg treatment rheumatology a4c disease product acr2021 clinical"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PAD #cardiology #sign #injection #ekg #treatment #rheumatology #a4c #disease #product #acr2021 #clinical